APP and Alzheimer disease: Various peptide fragments amyloid beta 1‐42 (Aβ1‐42) resulted from the abnormal cleavage of amyloid precursor protein (APP) generate deposits in the specific area of the brain leading to losing of memory and cognitive impairment in patients with AD 2.